Vvus stock price today

Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. VIVUS, Inc. (VVUS) Analyst Ratings, Estimates & Forecasts ...

VVUS.US | VIVUS Inc. Stock Price & News - WSJ Nov 02, 2019 · View the latest VIVUS Inc. (VVUS.US) stock price, news, historical charts, analyst ratings and financial information from WSJ. DOW JONES, A NEWS CORP COMPANY News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. VVUS - Vivus News - Barchart.com VIVUS, Inc. (Nasdaq: VVUS) today announced that it will report financial results and provide a business update for the fourth quarter of 2019 after the market close on Tuesday, March 3, 2020. The company

Real time VIVUS (VVUS) stock price quote, stock graph, news & analysis.

VVUS VIVUS, Inc. Stock Quote - FINVIZ.com - Stock Screener VIVUS, Inc. operates as a specialty pharmaceutical company primarily in the United States and the European Union. The company offers Qsymia for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body-mass index of 30 or greater (obese patients) or 27 or greater (overweight patients) in Vivus (VVUS) Stock Message Board - InvestorsHub Mar 26, 2020 · MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Nov. 5, 2007--VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that it has successfully concluded communications with the U.S. Food and Drug Administration (FDA), under the Special Protocol Assessment

VVUS Stock Quote - VIVUS, Inc. Common Stock Price - Nasdaq

Apr 03, 2020 · Wall Street is neutral on VIVUS, Inc. (VVUS). On average, analysts give the stock a Sell rating. The average price target is $5.375, which means analysts expect the stock to rise by 289.49% over the next twelve months. That average ranking earns the sto

VVUS:NASDAQ GS Stock Quote - VIVUS Inc - Bloomberg Markets

VVUS Stock Quote of Vivus Inc - InvestorPlace 5 Reasons Why VIVUS, Inc. (VVUS) Stock Should Be in Your Portfolio By Zacks Investment Research May 25, 2017 VIVUS is a biopharmaceutical company developing and commercializing innovative, next If You Had Bought VIVUS (NASDAQ:VVUS) Stock Five Years Ago ... Mar 09, 2019 · VIVUS, Inc. (NASDAQ:VVUS) shareholders will doubtless be very grateful to see the share price up 58% in the last quarter.But will that repair the damage for the weary investors who have owned this stock as it declined over half a decade? Probably not. Like a ship taking on water, the share price has sunk 92% in that time.

5 Feb 2020 Let's start up with the current stock price of VIVUS, Inc. (VVUS), which is $3.74 to be very precise. The Stock rose vividly during the last session 

Vivus Inc Stock Quote: VVUS Stock News, Quotes, Analysis ... Nov 05, 2019 · VVUS, Vivus Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Is VIVUS, Inc. (VVUS) Stock About to Get Hot Wednesday ... Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available. What's Happening With VVUS Stock Today? VIVUS, Inc. (VVUS) stock is trading at $3.76 as of 11:09 AM on Wednesday, Feb 5, a gain of $1.46, or 63.48% from the previous closing price of $2.30. VVUS Stock Quote - VIVUS, Inc. Common Stock Price - Nasdaq Stock quote for VIVUS, Inc. Common Stock Common Stock (VVUS) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.

VVUS | Stock Snapshot - Fidelity Apr 03, 2020 · VIVUS, Inc. (VVUS), a biopharmaceutical company, today announced the completion of its previously announced registered direct offering of 7,218,750 shares of the Company s common stock at a purchase price of $1.60 per share for gross proceeds of $11.55 million, before deducting the placement agent s fees and other offering expenses payable by VVUS Stock Quote of Vivus Inc - InvestorPlace